By Fineline Cube 
Shenzhen Core Medical Technology Co., Ltd, a developer of mechanical circulation assist systems, has reportedly secured over USD 100 million in a Series D financing round. The funding was co-led by Loyal Valley Capital, Social Security Fund Zhongguancun Independent Innovation Special Fund, Aramco Ventures’ Prosperity7Ventures, Costone Capital, and a prominent institutional investor. Delian Capital and New Alliance Capital also participated. The proceeds will support the incubation of cutting-edge technologies, accelerate product development, and expand international business.
Core Medical’s Innovative Products
Core Medical, a leader in miniaturized artificial hearts, highlights its in-house developed Corheart 6 implantable ventricular assist system (LVAD), DuoCor integrated fully magnetic levitation biventricular assist system (BIVAD), and CorVad interventional ventricular assist system (PVAD). These end-stage whole heart failure medical devices have received fast-track statuses in China.-Fineline Info & Tech